35th Vicenza Course on AKI&CRRT - 2017

Vicenza Course: 35 years of education - C. Ronco

Computers, Robotics and AI in Health Care: A Revolution Underway - F. Faggin

AKI pathophysiology - R. Bellomo

AKI: from clinical to molecular diagnosis - C. Ronco

The concept of Acute Kidney Disease (AKD) - L. Chawla

Pathways towards kidney recovery after AKI - J. Kellum

The kidney response to AKI: myths and facts - P. Romagnani

From AKI to CKD: maladaptive repair or inevitable destiny? - G. Castellano

Fluid management and AKI - R. Mehta

Personalized organ perfusion pressure targets during resuscitation - M. Pinsky

Results of the DoReMiFa Study: implications on RRT timing - M. Ostermann

Assessment of fluid status - S. Di Somma

The hemodynamic navigator - N. Levin

Use of diuretics - R. Bellomo

Ultrafiltration in fluid overloaded patients resistant to diuretics - A. Kazory

Vasopressin-2 receptor blockers: mechanism of action and clinical utility - Q. Qian

Evolution of AKI biomarkers and AKI alert systems - K. Kashani

Acidosis in AKI and CKD - Q. Qian

Potassium disorders and dyschloremia in AKI and CRRT - K. Kashani

The importance of a Nephrology Rapid Response Team - C. Ronco

Reducing AKI incidence using a KDIGO bundle - A. Zarbock

Mechanical Ventilation and the kidney - K. Liu

AKI in cardiac surgery - N. Katz

Critical Care Nephrology Cases Presentation

Results of the EUPHRATES Trial - M. Antonelli

The sepsis story in 2017 - J. Kellum

AKI in sepsis - R. Bellomo

Meaning of Biomarkers and Extracellular vesicles - V. Cantaluppi

AKI in cirrhosis and HRS - M. K. Nadim

AKI and HUS - A. Jorres

Fluids for shock: time for a change? - A. Shaw

From sorbent hemoprofusion to endotoxin removal - C. Ronco

CPFA: promises and results - G. Castellano

HCO membranes and sorbents for protection from tubular cell injury - V. Cantaluppi

Safety and efficacy of CytoSorb – Clinical experiences and current evidence - S. Mitzner

Extracorporeal membrane separation techniques for sepsis - W. Clark

Combined ECMO and CRRT sepsis - A. Bihorac

Neural control of inflammation in AKI - M. Okusa

Iron and Innate Immunity in AKI: Promising Therapeutic Targets - S. Swaminathan

AKI in the Patient with Cancer: imaging and biomarkers - M. Rosner

Fluids or no fluids; assessing volume responsiveness in the critically ill - K. Kalantari

Anti-inflammatory/Anti-oxidant extracorporeal support - C. Ronco

Electrolyte disturbances and AKI in genetic and rare diseases - G. Capasso

Cases presentation: Critical Care Nephrology Cases Presentation - R. Bellomo- J. Kellum & C

AKI in infants and children - S. Goldstein

Evolution of CRRT in neonates - C. Ronco

How I deal with AKI in neonates - Z. Ricci

Choice of Vascular Access and anticoagulation for CRRT - M. Schetz

Dose and timing of CRRT according to precision medicine - A. Zarbock

Biomarkers of Recovery: can we predict successful CRRT discontinuation? - L. Forni

Extracorporeal CO2 Removal: Rationale and techniques - M. Maggiorini

Cloud-based data collection for big data generation - C. Ronco

New techniques of GFR determination - R. Dorshaw

Biomarkers Kidney Stress Test and Renal Functional Reserve - F. Husain-Syed

How to prevent contrast-induced AKI - N. Pannu

AKI Risk Assessment in Cardiac Surgery: biomarkers and beyond - N. Katz

How do we integrate new technology into cost-constrained clinical practice - L. Forni